IGC Pharma (IGC) Deferred Taxes (2010 - 2016)
IGC Pharma (IGC) posted quarterly Deferred Taxes of $579.0 for Q1 2016, down 81.49% year-over-year from $3128.0 in Q2 2015, and down 81.49% quarter-over-quarter from $3128.0 in Q1 2015.
IGC Pharma (IGC) Deferred Taxes (2010 - 2016) Analysis & Trends
IGC Pharma (IGC) has reported Deferred Taxes for 7 consecutive years, with $579.0 the latest figure, recorded in Q1 2016.
- In Q1 2016, Deferred Taxes fell 81.49% year-over-year to $579.0; the TTM figure through Mar 2016 stood at $3707.0 (up 18.51% YoY), while the FY2017 annual figure was $18968.0, up 3175.99% from the prior year.
- Deferred Taxes declined to $579.0 in Q1 2016 per IGC's latest filing, from $3128.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $863953.0 in Q1 2012 and bottomed at -$522498.0 in Q1 2013.
- Historically, Deferred Taxes has averaged $33176.5 across 5 years, with a median of $1596.0 in 2013.
- On a YoY basis, Deferred Taxes climbed as much as 278.51% in 2013 and fell as far as 160.48% in 2013.
- IGC Pharma's Deferred Taxes stood at $498.0 in 2012, then jumped by 278.51% to $1885.0 in 2013, then soared by 684.67% to $14791.0 in 2014, then plunged by 78.85% to $3128.0 in 2015, then plunged by 81.49% to $579.0 in 2016.
- Business Quant data shows IGC's Deferred Taxes at $579.0 in Q1 2016, $3128.0 in Q1 2015, and $14791.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.66 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 579.00 |
| Mar 31, 2015 | 3,128.00 |
| Mar 31, 2014 | 14,791.00 |
| Dec 31, 2013 | 1,885.00 |
| Sep 30, 2013 | 1,507.00 |
| Jun 30, 2013 | 1,596.00 |
| Mar 31, 2013 | -522,498.00 |
| Dec 31, 2012 | 498.00 |
| Sep 30, 2012 | 3,040.00 |
| Jun 30, 2012 | -3,538.00 |
| Mar 31, 2012 | 863,953.00 |
| Mar 31, 2011 | 4.55 Mn |
| Dec 31, 2010 | 7,285.00 |
| Sep 30, 2010 | 17,951.00 |
| Jun 30, 2010 | -474,871.00 |